|
Pharmaceutical Name: Coccidiosis vaccine -- live oocysts
Features & Benefits:
Marketplace Advantages:
Gives producers flexibility to offer "drug free" birds
Differentiates birds from standard "feed-additive" broiler
Improves consumer friendly image of poultrymeat
Allows premium pricing to "green" markets
Eliminates residue concerns for consumers
Therapeutic Superiority:
Protects against all Eimeria spp. important to broilers
Birds remain protected for entire broiler cycle after a single administration
Reduces risk of late outbreaks
Eliminates undesirable side effects of coccidiostats
Eliminates risk of toxicity in non-target species
Attenuated strains remain apathogenic and sensitive after successive recycling on broiler farm
Improves protection of birds on cereal supplementation programs
No need for complicated drug rotation programs
Production Efficiencies:
Removal of coccidiostat allows for greater nutrient density in feed
Elimination of anti-coccidial rations results in fewer ration types necessary at feed mill
Reduces time spent flushing feed mill lines to clear coccidiostat residues
Reduces space requirements for coccidiostat storage
No withdrawal period means greater flexibility in planning and inventory of grower and finisher rations
Elimination of residue and regulatory worries associated with use of coccidiostats
Indications:
For the active immunization of chickens to reduce infection and clinical signs caused by E. acervulina, E. maxima, E. mitis, and E. tenella.
Paracox-5 is a registered trademark of Schering-Plough Animal Health Corporation. | 
